Home › Metastatic Cancer › Ohio › Columbus
Pag-aaral pangklinika para sa Metastatic Cancer sa Columbus, OH
Isang pag-aaral para sa Metastatic Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Columbus. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
- Mount Carmel East Hospital, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- at 13 pa
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
Nagre-recruitPhase 1
- ALX Center 10, Columbus
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Nagre-recruitPhase 2/3
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Nagre-recruitPhase 1/2
- Ohio State University, Columbus
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Nagre-recruitPhase 3
- The Mark H Zangmeister Center, Columbus
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Hilliard · 10 mi ang layo
SLV-154 Treatment of Advanced Cancers
Nagre-recruitPhase 1
- The James Outpatient Care West Center, Columbus
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Nagre-recruitPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Clinical Study Site, Columbus
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Ohio State University Hospital, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Nagre-recruitPhase 2
- Ohio State University Comprehensive Cancer Center, Columbus
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 2
- Ohio State University, Columbus
FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3
Nagre-recruitPhase 1
- The Ohio State University (OSU), Columbus
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Nagre-recruitPhase 1
- Ohio State University Comprehensive Cancer Center, Columbus
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Nagre-recruitPhase 3
- Research Site, Columbus
- Research Site, Hilliard · 10 mi ang layo
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Nagre-recruitPhase 1
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of LY4175408 in Participants With Advanced Cancer
Nagre-recruitPhase 1
- The Ohio State University (OSU) Wexner Medical Center, Columbus
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Nagre-recruitPhase 1/2
- OSU Brain & Spine Hospital, Columbus
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Nagre-recruitPhase 3
- Stefanie Spielman Comprehensive Breast Center at Olentangy River Road, Columbus
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Nagre-recruitPhase 3
- Ohio State University, James Cancer Hospital and Solove Research Institute, Columbus
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Nagre-recruitPhase 2/3
- The Ohio State University, Columbus
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Nagre-recruitPhase 1
- OSU Brain and Spine Hospital, Columbus
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen
Nagre-recruitPhase 3
- The Ohio State University Comprehensive Cancer Center, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Columbus
Pag-aaral para sa Metastatic Cancer sa ibang lungsod
- Houston, TX104 pag-aaral
- New York City, NY93 pag-aaral
- Nashville, TN70 pag-aaral
- Boston, MA63 pag-aaral
- Los Angeles, CA57 pag-aaral
- St. Louis, MO54 pag-aaral
- Arlington, VA53 pag-aaral
- Philadelphia, PA46 pag-aaral
- Chicago, IL45 pag-aaral
- San Antonio, TX44 pag-aaral
- Washington, DC43 pag-aaral
- Dallas, TX42 pag-aaral
Iba pang pag-aaral sa Columbus
- Non-Small Cell Lung Cancer57 pag-aaral
- Kanser sa Suso40 pag-aaral
- Kanser sa Ovary39 pag-aaral
- Kanser (lahat ng uri)38 pag-aaral
- Kanser sa Baga37 pag-aaral
- Acute Myeloid Leukemia35 pag-aaral
- Chronic Lymphocytic Leukemia28 pag-aaral
- Kanser ng Endometrium25 pag-aaral
- Kanser sa Prostate24 pag-aaral
- Multiple Myeloma24 pag-aaral
- Colorectal Cancer24 pag-aaral
- Melanoma21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.